Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127785172 | 12778517 | 2 | F | 20160407 | 20160922 | 20160926 | 20160928 | EXP | DE-ACTELION-A-US2016-140864 | ACTELION | 60.00 | YR | A | M | Y | 0.00000 | 20160928 | OT | DE | NL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127785172 | 12778517 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 6X A DAY | N | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | ||||||
127785172 | 12778517 | 2 | C | UPTRAVI | SELEXIPAG | 1 | Oral | U | 207947 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127785172 | 12778517 | 1 | Pulmonary arterial hypertension |
127785172 | 12778517 | 2 | Pulmonary arterial hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127785172 | 12778517 | HO |
127785172 | 12778517 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127785172 | 12778517 | Abdominal discomfort | |
127785172 | 12778517 | Chest pain | |
127785172 | 12778517 | Nausea | |
127785172 | 12778517 | Neuroendocrine tumour | |
127785172 | 12778517 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127785172 | 12778517 | 1 | 20151020 | 0 |